CompletedNot Applicable

Biomarkers in Tissue and Blood Samples From Patients With Early-Stage Non-Small Cell Lung Cancer

99 participantsStarted 2010-07

Plain-language summary

RATIONALE: Studying samples of blood and tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is studying biomarkers in tissue and blood samples from patients with early-stage non-small cell lung cancer.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

DISEASE CHARACTERISTICS: * Diagnosis of early-stage non-small cell lung cancer * T1 or T2, N0 disease * Had a lobectomy or greater resection with negative surgical margins (R0 resection) * Available tumor and lymph node specimens from patients enrolled on ACOSOG-Z0040 and ACOSOG-Z0030 trials * Node-negative with recurrent disease within 3 years (cases) * Node-negative patients without recurrent disease (controls) PRIOR CONCURRENT THERAPY: * See Disease Characteristics

What they're measuring

disease specific survival

Timeframe: Up to 10 years

overall survival

Timeframe: Up to 10 years

Trial details

NCT IDNCT01139944

SponsorAlliance for Clinical Trials in Oncology

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2014-01

View on ClinicalTrials.gov More Lung Cancer trials